source
- Court dismisses part of Lilly lawsuit against Empower, some claims can proceedA federal judge has dismissed part of Eli Lilly’s lawsuit alleging Empower Pharmacy misled customers about its compounded versions of the obesity drug tirzepatide. But the court said some of Lilly’…Endpoints · 2mo ago↗ source
- Supreme Court questions how far generics makers can go with 'skinny label' drugsWASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the pharmaceutical industry. In its final argument scheduled for this term, the high court…Endpoints · 2mo ago↗ source
- Avalyn's upsized IPO; Alector ends another study in GSK partnership🔔 Avalyn Pharma’s $300M IPO: The Boston, MA-based biotech is selling over 16.5 million shares at $18 apiece. The company is set to start trading as {$AVLN} on the Nasdaq Thursday ...